| 000 | 01182 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516033915.0 | ||
| 264 | 0 | _c20110927 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1531-703X | ||
| 024 | 7 |
_a10.1097/CCO.0b013e3283477a94 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSubbiah, Vivek | |
| 245 | 0 | 0 |
_aPhase 1 clinical trials for sarcomas: the cutting edge. _h[electronic resource] |
| 260 |
_bCurrent opinion in oncology _cJul 2011 |
||
| 300 |
_a352-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 700 | 1 | _aKurzrock, Razelle | |
| 773 | 0 |
_tCurrent opinion in oncology _gvol. 23 _gno. 4 _gp. 352-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CCO.0b013e3283477a94 _zAvailable from publisher's website |
| 999 |
_c20784253 _d20784253 |
||